$RSKD Balance Sheet | Understand Stock

$RSKD

$8.98 -$0.24 (2.6%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Short-term deposits
Accounts receivable, net
Prepaid expenses and other current assets
Short-term investments
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Deferred contract acquisition costs
Other assets, noncurrent
Total assets
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable
Accrued compensation and benefits
Guarantee obligations
Provision for chargebacks, net
Operating lease liabilities, current
Accrued expenses and other current liabilities
Total current liabilities
Operating lease liabilities, noncurrent
Other liabilities, noncurrent
Total liabilities
Temporary Equity, Carrying Amount, Attributable to Parent
Shareholders’ equity:
Common stock, value, issued
Treasury shares at cost, 52,025,888 and 30,049,351 ordinary shares as of December 31, 2025 and 2024, respectively
Additional paid-in capital
Accumulated other comprehensive profit (loss)
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments